|
|
|
Lemaitre Vascular Inc (NASDAQ: LMAT) |
|
|
|
| |
Lemaitre Vascular Inc Outlook |
On May 2 2024 the Lemaitre Vascular Inc provided following guidance
LeMaitre Vascular Inc. (Nasdaq: LMAT), a leading provider of vascular devices, implants, and services, announced its financial results for the first quarter of 2024 on May 2nd. The company reported strong performance in the quarter, with revenues exceeding expectations and demonstrating solid growth in key product segments.
In addition to the positive financial results, LeMaitre Vascular Inc. also declared a quarterly dividend of $0.16 per share for the quarter. This dividend reflects the company's continued commitment to returning value to its shareholders and maintaining a strong financial position.
Looking ahead, LeMaitre Vascular Inc. provided guidance for the remainder of 2024, indicating optimism about the company's growth prospects and ability to capitalize on new opportunities in the vascular device market. With a focus on innovation and customer satisfaction, LeMaitre Vascular Inc. is well-positioned to continue its success in the coming quarters.
|
On February 27 2024 the Lemaitre Vascular Inc provided following guidance
LeMaitre Vascular Inc., a leading provider of vascular devices, implants, and services, released its financial results for the fourth quarter of 2023 on February 27, 2024. The company reported strong performance during this period, with revenue exceeding expectations and demonstrating significant growth. As a reflection of its financial success, LeMaitre also announced a quarterly dividend of $0.16 per share for its shareholders.
Additionally, the company provided guidance for the 2024 fiscal year, outlining its strategies for continued growth and success. With a focus on innovation, customer satisfaction, and strategic partnerships, LeMaitre is positioned to capitalize on emerging trends in the vascular healthcare industry and further strengthen its position as a leader in the market.
Overall, LeMaitre Vascular Inc. remains committed to delivering value to its shareholders, customers, and patients through its cutting-edge products and services. With a solid financial foundation and a clear vision for the future, the company is well-positioned for continued success in the years to come.
|
On February 13 2024 the Lemaitre Vascular Inc provided following guidance
LeMaitre Vascular, Inc. has announced that it will be reporting its financial results for the fourth quarter of 2023 on February 27, 2024, after the market closes. The company will also be holding a conference call at 5:00 PM ET on the same day to provide further details about the results, highlight important developments in the business, and share its outlook for the future. Investors and interested parties are encouraged to participate in the conference call to gain insights into LeMaitre Vascular's performance and future prospects.
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.
